Form 4: Nevro Corp Director Michael DeMane Reports Acquisition of Shares and RSU Grant

Director Michael F. DeMane reports acquisition of shares through restricted stock units (RSUs) and adjustments to beneficial ownership via trust transfers.

Summary

• Michael F. DeMane, a director of Nevro Corp, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On May 23, 2024, DeMane acquired 19,169 shares of common stock through restricted stock units (RSUs).
• These RSUs will vest on the earlier of one year from May 23, 2024, or the next Annual Meeting following that date, contingent on continued service to Nevro Corp.
• The filing also reflects transfers of shares between various trusts associated with DeMane and his family, resulting in adjustments to his indirect ownership.
• Specifically, transfers occurred involving the Michael F. DeMane 2017 Family SLAT Trust, the Michael F. DeMane Revocable Trust U/A 10/07/2011, and the Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, with the RSU grant suggesting a positive outlook but not definitively so.

Positives

• The acquisition of shares through RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continued service to the Issuer.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates